These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 7514220
1. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. Carter AJ. J Pharmacol Exp Ther; 1994 May; 269(2):573-80. PubMed ID: 7514220 [Abstract] [Full Text] [Related]
2. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice. D'Hooge R, Raes A, Hiramatsu M, Mori A, Van Bogaert PP, De Deyn PP. Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924 [Abstract] [Full Text] [Related]
3. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site. Hood WF, Gray NM, Dappen MS, Watson GB, Compton RP, Cordi AA, Lanthorn TH, Monahan JB. J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886 [Abstract] [Full Text] [Related]
4. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex. Carter AJ, Bechtel WD, Grauert M, Harrison P, Merz H, Stransky W. J Pharmacol Exp Ther; 1995 Dec; 275(3):1382-9. PubMed ID: 8531106 [Abstract] [Full Text] [Related]
5. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex. Grauert M, Bechtel WD, Ensinger HA, Merz H, Carter AJ. J Med Chem; 1997 Aug 29; 40(18):2922-30. PubMed ID: 9288174 [Abstract] [Full Text] [Related]
6. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors. Tan-No K, Esashi A, Nakagawasai O, Niijima F, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Tadano T. Brain Res; 2004 May 15; 1008(1):49-53. PubMed ID: 15081381 [Abstract] [Full Text] [Related]
7. The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nucleus accumbens. Kosowski AR, Liljequist S. J Pharmacol Exp Ther; 2004 Nov 15; 311(2):560-7. PubMed ID: 15256539 [Abstract] [Full Text] [Related]
8. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. Ferkany JW, Hamilton GS, Patch RJ, Huang Z, Borosky SA, Bednar DL, Jones BE, Zubrowski R, Willetts J, Karbon EW. J Pharmacol Exp Ther; 1993 Jan 15; 264(1):256-64. PubMed ID: 8423528 [Abstract] [Full Text] [Related]
9. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L. Br J Pharmacol; 1998 Nov 15; 125(6):1258-66. PubMed ID: 9863655 [Abstract] [Full Text] [Related]
10. Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex. Itzhak Y, Stein I. J Pharmacol Exp Ther; 1992 Aug 15; 262(2):464-70. PubMed ID: 1386882 [Abstract] [Full Text] [Related]
11. Competitive NMDA receptor antagonists and agonists: effects on spontaneous alternation in mice exposed to cerebral oligemia. Jóźwiak L, Łukawski K, Czuczwar SJ, Sieklucka-Dziuba M. Pol J Pharmacol; 2004 Aug 15; 56(1):59-66. PubMed ID: 15047978 [Abstract] [Full Text] [Related]
12. Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice. Ishimaru H, Katoh A, Suzuki H, Fukuta T, Kameyama T, Nabeshima T. J Pharmacol Exp Ther; 1992 Apr 15; 261(1):349-52. PubMed ID: 1532836 [Abstract] [Full Text] [Related]
13. Intrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptors. Watanabe C, Orito T, Watanabe H, Mizoguchi H, Yonezawa A, Yanai K, Mobarakeh JI, Onodera K, Sakurada T, Sakurada S. Eur J Pharmacol; 2008 Feb 26; 581(1-2):54-63. PubMed ID: 18155693 [Abstract] [Full Text] [Related]
14. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Irifune M, Shimizu T, Nomoto M, Fukuda T. Pharmacol Biochem Behav; 1995 Feb 26; 51(2-3):291-6. PubMed ID: 7667342 [Abstract] [Full Text] [Related]
15. Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice. Poleszak E, Wośko S, Serefko A, Szopa A, Wlaź A, Szewczyk B, Nowak G, Wlaź P. Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct 01; 46():29-35. PubMed ID: 23774195 [Abstract] [Full Text] [Related]
17. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T, Marshall GR, Hill RG, Kemp JA. Br J Pharmacol; 1998 Aug 01; 124(8):1767-73. PubMed ID: 9756395 [Abstract] [Full Text] [Related]
18. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine. Witkin JM, Gasior M, Heifets B, Tortella FC. J Pharmacol Exp Ther; 1999 May 01; 289(2):703-11. PubMed ID: 10215643 [Abstract] [Full Text] [Related]